EDI launches new anti-auristatin monoclonal antibodies and ELISA kits

Epitope Diagnostics is proud to announce that a new set of monoclonal antibodies specific to auristatins is now commercially available. The novel clones are specific against detecting monomethyl auristatin E (MMAE) and monomethyl auristatin F (MMAF), two anti-cancer compounds. Using these new monoclonal antibodies, we were able to successfully develop highly sensitive MMAE-ADC and MMAF-ADC ELISA kits.

These monoclonal antibodies are very stable at 2-8°C and come in a PBS buffer. The isotype of both antibodies is IgG1.

We have confirmed that it is possible for these antibodies to be coated on a solid phase, as well as having the capability to be used as a detection antibodies. Biotinylation and HRP-conjugation is also a possibility; these are available upon request.

All products are intended for research use only.

 

Specifications

Product Name

Cat. no.

 

Product Name

 

Cat. no.

 

Product Name

Cat. no.

 

Product Name

Cat. no.

We welcome our colleagues to develop their own assays with these antibodies for their own specific applications. We are also open to collaboration.

For quotations and other inquiries, please contact us at cs@epitopediagnostics.com.